
Researchers unravel how ADEP antibiotics work
Fighting antimicrobial resistance has been named one of the prioritary goals by the World Health Organization (WHO). However, as the number of...

Healx Ltd raises $56m in Series B financing
The financing was led by Atomico and joined by Intel Capital, Global Brain and btov Partners as new investors. Existing investors from a US$10m...

Pharvaris BV raises $66m to advance oral HAE drug
The Series B financing was led by Foresite Capital. New investors Bain Capital Life Sciences, venBio and Venrock, as well as the investors of a €15m...

Vaximm goes East for cancer vaccine deal
T-cell immunotherapy expert Vaximm plans to use Artificial Intelligence (AI) to develop personalised cancer vaccines. The biotech is collaboration...

Lundback swallows migraine drug maker Alder
Alder's first-in-class monoclonal antibody for migraine prevention, eptinezumab, targets the calcitonin gene-related peptide and faces FDA...

New risk factor for autism and epilepsy identified
The KCC2 K+Cl– co-transporter is critical for the health and maturity of neurons, as it helps to maintain a low concentration of chloride ions in...

Pro-apoptotic protein blocks autoimmunity
John Rizk discovered that the SMAC protein (Second mitochondria-derived activator of caspase) besides triggering cancer cell apoptosis have a second...